Koers Pure Global Cannabis Inc. Other OTC
Aandelen
PRCNF
CA74625A1075
Farmaceutische producten
Omzet 2017 | - | Omzet 2018 | - | Marktkapitalisatie | 24,16 mln. 22,25 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | - 0 | Nettowinst (verlies) 2018 | -23 mln. -21,18 mln. | EV/omzet 2017 * | - |
Nettoschuld 2017 | 211K 194K | Nettoschuld 2018 | 4,49 mln. 4,13 mln. | EV/omzet 2018 | - |
K/w-verhouding 2017 * |
-
| K/w-verhouding 2018 |
-0,72
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 83,64% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Vik Chopra
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjeev Goel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Lavergne
PRN | Corporate Officer/Principal | - | 30-07-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jane E. Pagel
BRD | Director/Board Member | - | 01-07-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+42,07% | 6,28 mld. | |
-21,20% | 4,25 mld. | |
+5,38% | 3,36 mld. | |
-16,98% | 2,96 mld. | |
-5,82% | 2,45 mld. | |
+45,47% | 1,97 mld. | |
-12,67% | 1,61 mld. | |
-3,91% | 1,6 mld. | |
+44,56% | 1,51 mld. |